Copyright: ©Author(s) 2026.
World J Gastroenterol. Oct 28, 2026; 32(40): 116827
Published online Oct 28, 2026. doi: 10.3748/wjg.116827
Published online Oct 28, 2026. doi: 10.3748/wjg.116827
Table 1 Characteristics and outcome of the patients with anal fistulas, mean ± SD/n (%)
| Variables | Perianal fistula in CD (n = 69) | Cryptoglandular anal fistula (n = 182) | P value |
| Age | 26.03 ± 7.75 | 42.70 ± 12.08 | < 0.001 |
| Male/female | 50/19 | 158/24 | 0.007 |
| Duration of anal fistula (month) | 14.61 ± 22.09 | 25.51 ± 49.73 | < 0.001 |
| Duration of CD (month) | 8.87 ± 18.29 | - | - |
| Previous fistula surgery | 32 (46.4) | 94 (51.6) | > 0.05 |
| Biological agents (such as anti-tumor necrosis factor) | 24 (34.8) | - | - |
| magnetic resonance imaging feature | |||
| Neither transmural inflammation nor active proctitis | 12 (17.4) | 147 (80.7) | < 0.001 |
| Only transmural inflammation | 11 (15.9) | 16 (8.8) | < 0.001 |
| Only active proctitis | 25 (36.2) | 16 (8.8) | < 0.001 |
| Transmural inflammation and active proctitis | 21 (30.4) | 3 (1.6) | < 0.001 |
- Citation: Xu ZP, Li L, Sun GD, Wu YY, Cai EW, Wen K, Shao WJ, Chen YG. Magnetic resonance imaging predicts perianal fistula in Crohn’s disease. World J Gastroenterol 2026; 32(40): 116827
- URL: https://www.wjgnet.com/1007-9327/full/v32/i40/116827.htm
- DOI: https://dx.doi.org/10.3748/wjg.116827